MCK

McKesson Corporation

$1082.59

2.19%
SectorHealthcareIndustryMedical DistributionCountryUnited States

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care.

Source: Yahoo Finance
AI summary

Price & performance

1M+17.1%
3M+22.3%
YTD+30.6%
1Y+27.5%
52-week range—
Beta0.01
Full chart and returns against a benchmark

Q-Score

80/ 100

Quality against peers; 50 is the peer median.

Growth71
Risk78
Performance70
Valuation70
Profitability61
Leverage76
Sentiment51
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue$403.4B+12.4%
Net income$4.8B+44.5%
Net margin1.2%+0.3 pts
Historical fundamentals

Revenue exposure

Regions, segments, customers and suppliers

Valuation

MCKIndustryP/E26.5928.60P/S0.300.25EV/EBITDA18.1617.46P/B——PEG1.610.72
Dividend yield0.32%
Every valuation metric

Earnings

Feb 3next report
EPS estimate$10.75
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate